Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QIAGEN (QGENF) - Star of Germany's Biotechs -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (54)	3/20/1998 10:42:00 AM
From: Andreas Helke	Read Replies (1) \| Respond to of 122

I think the major problem is that too much money is chasing too few stocks. The Neue Markt is pretty new and was intended to be a place where innovative small companies could get a listing with less strict requierements than on germanys big boards. If you got into one of the later IPOs it was a shure double over night. I assume that some of the early IPOs were priced too low and now people see how much money they could have made if they had bought those companies early. 1996 we had no good place for innovative growth companies. Therefore Qiagen and Pfeiffer Vacuum decided that they would avoid the german market and do their IPO on the NASDAQ. Now Qiagen is already listed on the Neue Markt and Pfeiffer intends to get there too. That we have a serious bull market helps of course. Even the DAX with the 30 biggest companies went up 50% last year. The Neue Markt already doubled this year. Andreas

To: Vector1 who wrote (54)	3/20/1998 10:47:00 AM
From: squetch	Read Replies (1) \| Respond to of 122

V1, I can't tell you what is going on in Germany, but do know a little about Sweden. The folks there for the first time in 96(?) were able to invest in companies w/ no earnings. Those stocks went crazy. I actually read what I could of some Swedish stock board. I corresponded a little w/ a guy there. I don't know what happened to all the stocks, but one biotech I follow got crushed. Here is how the sentiment has turned>>All I can say right now is that here is only lack of news. All innovation companys in Sweden really suffer now. It seems like Swedish investors are not interested in those kind of companys anymore. But someday they will return, and then it will hit hard :-)<< The QGENF puts seem expensive to me. I am no expert on them and wondered if anyone w/ more experience had an opinion. squetch